Highlights society guidelines recommending non-endoscopic biomarker testing, such as Lucid's EsoGuard Esophageal DNA Test, as an acceptable alternative to endoscopy "This update is an important ...

In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing ...

outperforming the standard of care (i.e., AJCC staging) and the CP-GEP genomic test.” SLNB helps determine whether melanoma has spread to nearby lymph nodes. Current NCCN guidelines recommend ...

About Lucid DiagnosticsLucid Diagnostics Inc. is a commercial-stage, cancer prevention ... national-comprehensive-cancer-network-nccn-guidelines-now-include-esophageal-precancer-screening ...

Highlights society guidelines recommending non-endoscopic biomarker testing, such as Lucid's EsoGuard Esophageal DNA Test, as an acceptable alternative to endoscopy Lucid Diagnostics Inc., markets the ...